Kaoru Miyakawa

894 citations
41 papers · 695 indexed · h-index 16
Topics
Liver Disease Diagnosis and Treatment (11 papers)Gallbladder and Bile Duct Disorders (10 papers)Hepatitis C virus research (9 papers)
Partner nations
JapanUnited States

In The Last Decade

Kaoru Miyakawa

41 papers receiving 674 citations

Peers

Kaoru Miyakawa
Comparison fields: 5 of 75
  • Hepatology 276
  • Epidemiology 263
  • Surgery 173
  • Pulmonary and Respiratory Medicine 143
  • Oncology 135
Replace Takenari Yamanaka with:
Takenari Yamanaka Japan
Olivier Romano France
Chi-Hung Cheng Taiwan
Edith M.M. Kuiper Netherlands
E. Vuillemin France
S Furuta Japan
Ken Tanikawa Japan
Shuangshuang Zhao China
Dekai Qiu China
Kaoru Miyakawa relative to Takenari Yamanaka Japan Takenari Yamanaka's profile →
Citations per field
00.5×1.5×1.8×
Takenari Yamanaka · 1×
Citations per year

Countries citing papers authored by Kaoru Miyakawa

Since Specialization
Citations

This map shows the geographic impact of Kaoru Miyakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaoru Miyakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaoru Miyakawa more than expected).

Fields of papers citing papers by Kaoru Miyakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaoru Miyakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaoru Miyakawa. The network helps show where Kaoru Miyakawa may publish in the future.

Co-authorship network of co-authors of Kaoru Miyakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kaoru Miyakawa. A scholar is included among the top collaborators of Kaoru Miyakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaoru Miyakawa. Kaoru Miyakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 25
2 15
3 2
4 23
5 5
6 8
7 6
8 2
9 11
10 12
11
Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis.
17
12 1
13 43
14 8
15 10
16 42
17 140
18 16
19 32
20
[Anticancer effect of peplomycin on advanced recurrent breast cancer].
2

About Kaoru Miyakawa

Kaoru Miyakawa is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 41 papers that have together received 695 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Gallbladder and Bile Duct Disorders (10 papers) and Hepatitis C virus research (9 papers). The work is most often cited by research in Hepatology (276 citations), Epidemiology (263 citations) and Pharmacology (58 citations). Kaoru Miyakawa has collaborated with scholars based in Japan and United States. Frequent co-authors include Shinichi Ohkawa, Kazuo Tarao, Motonori Fukumura, Kazutoshi Shindo, Setsuo Tamai, Yasushi Rino, Naoyuki Okamoto, Takahiro Masaki, Toshio Imada and Akio Shimizu. Their work appears in journals such as Journal of Clinical Oncology, Cancer and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026